Immunotherapy — drugs that use your body’s immune system to kill diseases — has become an important tool for treating some types of cancer. And now, people with advanced bladder cancer have an immunotherapy option.
It makes sense to know the risk factors that you can control — and then avoid or eliminate them entirely to lower your risk of developing certain cancers. Here is our collection of advice to help you know more about your risk of developing breast, bladder, colon or skin cancers.
With age come wisdom, experience and, unfortunately, a higher risk of bladder cancer. Certainly, bladder cancer can occur at any age, but it’s more common in older men and much less frequently an issue in younger men and women. Time gives you more chances to become exposed to harmful chemicals that get processed through your … Read More
Like the people they affect, each and every tumor is unique. Because of this, a “one size fits all” approach to cancer treatment does not work, especially in the most challenging cases. But cancer treatment is changing. Understanding each tumor’s unique composition is leading to treatments based on each individual’s needs. This understanding comes through … Read More
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Many people don’t realize that smoking tobacco is the single most important known risk factor for bladder cancer, according to the National Institutes for Health. The effects of cigarette smoke toxins entering your body have received a lot of attention, but far too little attention has been given to how those toxins make their way … Read More
For the first time, our urology and nephrology programs are each ranked No. 1 in the United States by U.S. News & World Report in the publication’s “Best Hospitals 2013” rankings. We are both delighted and humbled by this recognition. Both programs are part of Cleveland Clinic’s Glickman Urological & Kidney Institute, where we have … Read More